New Westminster, Canada

Natalia Pokrovskaia

This inventor holds 11 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Novartis Ag, Xenon Pharmaceuticals Inc., Eli Lilly and Company. Active years: 2011-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Natalia Pokrovskaia. Retrieved from https://idiyas.com/inventor/natalia-pokrovskaia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 8.9

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • New Westminster, CA (US) (2011)
  • New Westminster, CA (2011 - 2013)
  • Burnaby, CA (2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Inventor Natalia Pokrovskaia

Introduction

Natalia Pokrovskaia is a notable inventor based in New Westminster, Canada. With a remarkable portfolio comprising 11 patents, she has made significant contributions to the field of organic compounds and pharmaceutical innovations. Her work has implications for human health, particularly in the modulation of key biological processes.

Latest Patents

Natalia's latest inventions include a range of heterocyclic derivatives that modulate the activity of stearoyl-CoA desaturase. One of her groundbreaking patents involves methods for using these derivatives, along with pharmaceutical compositions that comprise them. Additionally, her work on aminothiazole derivatives as inhibitors of human stearoyl-CoA desaturase presents new methods for treating SCD-mediated diseases or conditions in mammals. These advancements illustrate her commitment to addressing complex health issues with innovative solutions.

Career Highlights

Throughout her career, Natalia has worked with prestigious companies like Novartis AG and Xenon Pharmaceuticals Inc. These experiences have allowed her to combine her research talents with commercial applications, facilitating the translation of her inventions into viable pharmaceutical products.

Collaborations

Natalia has engaged in collaborative efforts alongside accomplished colleagues such as Jianmin Fu and Shaoyi Sun. These partnerships have likely fostered a rich exchange of ideas and expertise, further enhancing the quality and impact of her work.

Conclusion

In conclusion, Natalia Pokrovskaia is a distinguished inventor whose innovative contributions continue to shape the landscape of pharmaceutical research. Her patents not only demonstrate her ingenuity but also her dedication to improving human health through scientific advancements. As she continues her work, the potential for future innovations remains promising.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…